UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK

Fitchett, JR; Head, MG; Atun, R; (2013) Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK. Vaccine , 31 (50) 5930 -5933. 10.1016/j.vaccine.2013.10.048. Green open access

[thumbnail of 1-s2.0-S0264410X13014266-main.pdf]
Preview
PDF
1-s2.0-S0264410X13014266-main.pdf

Download (768kB)

Abstract

Financing for global health is a critical element of research and development. Innovations in new vaccines are critically dependent on research funding given the large sums required, however estimates of global research investments are lacking. We evaluate infectious disease research investments, focusing on immunology and vaccine research by UK research funding organisations. In 1997–2010, £2.6 billion were spent by public and philanthropic organisations, with £590 million allocated to immunology and vaccine research. Preclinical studies received the largest funding amount £505 million accounting for 85.6% of total investment. In terms of specific infection, “the big three” infections dominated funding: HIV received £127 million (21.5% of total), malaria received £59 million (10.0% of total) and tuberculosis received £36 million (6.0% of total). We excluded industry funding from our analysis, as open-access data were unavailable. A global investment surveillance system is needed to map and monitor funding and guide allocation of scarce resources.

Type: Article
Title: Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.vaccine.2013.10.048
Publisher version: http://dx.doi.org/10.1016/j.vaccine.2013.10.048
Language: English
Additional information: This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Vaccine, Immunology, Infectious disease, Public health policy, Research investments, Research and development
UCL classification: UCL
URI: https://discovery.ucl.ac.uk/id/eprint/1416661
Downloads since deposit
137Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item